Emergency department (ED) visits among teenage girls doubled for eating disorders and tripled for tic disorders; World Health Organization official expresses concern for lack of COVID-19 testing; history of sexual violence among women may worsen their cardiovascular (CVD) health.
The representation of Black physicians is alarmingly low, but the opportunities for change are possible and urgent. Health care leaders and human resource departments need to address these disparities, and increasing diversity among their workforce is an excellent place to begin.
Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, speaks on the key discussions to be held at the 2022 Community Oncology Conference for in-person attendees.
The FDA is considering a second COVID-19 booster dose of the mRNA COVID-19 vaccines; use of the unproven COVID-19 therapies hydroxychloroquine and ivermectin has been significantly greater in the highest vs lowest Republican vote share counties; infertility treatments associated with vascular and pregnancy-related complications.
Jacob Sands, MD, who leads the small cell lung cancer research program at Dana-Farber Cancer Institute, speaks with The American Journal of Managed Care (AJMC®) about the need for more patients who meet the criteria for lung screening to catch cancer before it reaches an advanced stage.
Biden administration officials request additional funding from Congress to manage the global COVID-19 pandemic; New York delays its COVID-19 booster vaccine mandate for health care workers amid staffing shortages; study finds racism affected treatment decisions and led to care disparities among Black patients.
Researchers compared drug costs among hospitals, specialty pharmacies, and physician offices.
Robert Sidbury, MD, MPH, chief of the Division of Dermatology at Seattle Children's Hospital, discusses risk factors involved in the pathogenesis of atopic dermatitis and several diagnostic methods.
Japanese children of parents whose family business was primarily industry, including agriculture, forestry, and fisheries, had a greater risk of atopic dermatitis (AD) development.
AHIP released a report looking at the price markups for 10 drugs that can be delivered more affordably through specialty pharmacies, including 3 drugs with multiple biosimilars available.
Asthma, aspirin-exacerbated respiratory disease, and nasal cytology were identified as predictors of chronic rhinosinusitis with nasal polyps recurrence.
A JAMA Dermatology study found that greater exposure to air pollutants, such as carbon monoxide and fine particulate matter, were significantly associated with later psoriasis flares.
Patients who utilized a patient-reported outcome (PRO) symptom measurement tool reported superior postdischarge outcomes after lung cancer surgery compared with those who received usual care.
President Joe Biden's FDA nominee reaches final confirmation vote; Georgia bill that extends Medicaid coverage for low-income moms advances to House of Representatives; New Mexico bill aims to legalize test strips to detect the presence of fentanyl.
By making diligent compliance efforts a priority in the years ahead, health plans can shore up existing processes to achieve financial success and ensure risk adjustment as regulatory bodies take aim at organizational missteps.
Risankizumab was shown to be highly effective in patients with moderate to severe psoriasis of tertiary medical centers in Italy, in which response was found to be significantly affected by smoking, and incidence of psoriatic arthritis.
The FDA delays its decision on Pfizer/BioNTech’s COVID-19 vaccine in young children; the Federal Trade Commission (FTC) will vote on whether to investigate pharmacy benefit managers (PBMs); nearly half of high-volume antibiotic prescribers are located in Southern states.
Children with moderate to severe atopic dermatitis were found to be more likely to report suboptimal sleep and attention regulation outcomes.
Researchers in the United Kingdom compared the potential impact on carbon footprint and asthma symptom control of switching maintenance therapy to a dry powder inhaler vs continuing with a metered dose inhaler containing hydrofluorocarbon propellant.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Robert Sidbury, MD, MPH, chief, Division of Dermatology, Seattle Children's Hospital, speaks on the inflammatory mechanisms of atopic dermatitis and risk of comorbidities in affected patients.
Researchers reviewed advances in the management of chronic rhinosinusitis, with and without nasal polyps, from 2020 to 2021.
A bipartisan congressional report estimates overdose deaths cost the United States $1 trillion yearly; 4 states announce plans to lift their statewide mask mandates for schools; study finds greater risk of pregnancy complications in expectant mothers with moderate COVID-19 symptoms.
Poor agreement was identified regarding MRI- and classification-defined axial spondyloarthritis (axSpA) and inflammatory back pain diagnoses in patients with psoriatic disease.
The CDC's wastewater monitoring program will soon begin evaluating more water samples for COVID-19; vaccine guidance changes for individuals who are immunocompromised may be forthcoming; exposure to air pollution levels vastly greater than that advised by World Health Organization guidelines.
